Clinical Trial Update: The Safety and Efficacy of Risperidone as Adjunctive Therapy to Mood Stabilizers in the Long-term Treatment of Bipolar Mania [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating risperidone as an adjunct to mood stabilizers for long-term treatment of bipolar mania has completed. The update summarizes safety and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Risperdal (risperidone)

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Bipolar Disorder | Phase 4 | Status: COMPLETED